SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-033099
Filing Date
2019-06-28
Accepted
2019-06-28 17:17:27
Documents
11
Period of Report
2019-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv524516_8k.htm 8-K 29445
2 EXHIBIT 1.1 tv524516_ex1-1.htm EX-1.1 210888
3 EXHIBIT 4.1 tv524516_ex4-1.htm EX-4.1 107815
4 EXHIBIT 4.2 tv524516_ex4-2.htm EX-4.2 105592
5 EXHIBIT 4.3 tv524516_ex4-3.htm EX-4.3 111867
6 EXHIBIT 5.1 tv524516_ex5-1.htm EX-5.1 9582
7 EXHIBIT 99.1 tv524516_ex99-1.htm EX-99.1 14981
8 GRAPHIC tv524516_ex5-1img01.jpg GRAPHIC 8206
9 GRAPHIC tv524516_ex5-1img02.jpg GRAPHIC 7047
10 GRAPHIC tv524516_ex5-1img03.jpg GRAPHIC 5833
11 GRAPHIC tv524516_ex99-1img01.jpg GRAPHIC 19929
  Complete submission text file 0001144204-19-033099.txt   648515
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 19930456
SIC: 8731 Services-Commercial Physical & Biological Research